During the past decade, Tamworth Base Hospital conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tamworth Base Hospital" #1 sponsor was "Australasian Gastro-Intestinal Trials Group" with 2 trials, followed by "ETOP IBCSG Partners Foundation" with 2 trials sponsored, "University of Sydney" with 2 trials sponsored, "Belinda Howe" with 1 trials sponsored and "Breast Cancer Trials, Australia and New Zealand" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tamworth Base Hospital" #1 collaborator was "Breast International Group" with 3 trials as a collaborator, "Australian and New Zealand Intensive Care Society Clinical Trials Group" with 2 trials as a collaborator, "Australian and New Zealand Urogenital and Prostate Cancer Trials Group" with 2 trials as a collaborator, "Cancer Trials Ireland" with 2 trials as a collaborator and "National Health and Medical Research Council, Australia" with 2 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "Tamworth Base Hospital" are "Breast Cancer" (2 trials), "Fallopian Tube Cancer" (2 trials), "Ovarian Cancer" (2 trials), "Primary Peritoneal Cavity Cancer" (2 trials) and "Prostatic Neoplasms" (2 trials). Many other conditions were trialed in "Tamworth Base Hospital" in a lesser frequency.

Most popular intervention types in "Tamworth Base Hospital" are "Drug" (10 trials), "Behavioral" (2 trials), "Biological" (2 trials), "Other" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Enzalutamide" (2 trials), "Nivolumab" (2 trials), "Cisplatin" (1 trials), "Conventional NSAA" (1 trials) and "Current standard PD training" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tamworth Base Hospital" are 7 trials for "All" genders, 5 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Tamworth Base Hospital". undefined are not yet recruiting, 4 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Tamworth Base Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Tamworth Base Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".